About Anshul Specialty Molecules Private Limited
Data last updated: 11 January 2026
Anshul Specialty Molecules Private Limited is a private limited company based in Mumbai, Maharashtra, India. It specialises in specialty chemicals, a part of the broader chemicals and materials sector. Incorporated on 05 October 1971, the company has been in operation for over 55 years.
Registered with ROC Mumbai under CIN U24100MH1971PLC015364.
Capital: an authorised share capital of ₹3 Cr and a paid-up capital of ₹29.42 Lakh. Formerly known as Anshul Specialty Molecules Limited. It is led by directors including Ashwin Champraj Shroff and Ravi Ashwin Shroff.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Flexcel Park, Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹177.17 Cr, a growth of 18% compared to the previous year.
The company has a workforce of approximately 205 employees as per the latest available data.
The company is associated with 1 brand - Anshul Specialty Molecules. As per MCA filings, the company has open charges of ₹57.27 Cr and satisfied charges of ₹3.49 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anshulchemicals.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressFlexcel Park C Wing 2Nd Floor S.V. Road Near 24 Karat Multiplex Joge, Shwari (W), Mumbai, Maharashtra, India – 400102
-
IndustryChemicals and Materials, Specialty Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Anshul Specialty Molecules Private Limited
Anshul Specialty Molecules Private Limited has one previous CIN (Corporate Identification Number): U24100MH1971PLC015364. The current CIN is U24100MH1971PTC015364, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100MH1971PTC015364 | Current |
| U24100MH1971PLC015364 | Previous |
Associated Brands with Anshul Specialty Molecules Private Limited
Anshul Specialty Molecules Private Limited operates one associated brand: Anshul Specialty Molecules. These brands represent Anshul Specialty Molecules Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality specialty chemicals for APIs, flavors, fragrances, and custom synthesis. | anshulchemicals.com |
Competitors & Alternatives of Anshul Specialty Molecules Private Limited
Brands and companies operating in the same space as Anshul Specialty Molecules Private Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Beijing Biostar Technologies
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Hikal
|
APIs and intermediates are produced via custom synthesis and research. | Mumbai, India, India | 1988 |
Snapdragon Chemistry
|
Drug discovery and development service provider | Cambridge, United States, United States | 2014 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Business Activity of Anshul Specialty Molecules Private Limited
Anshul Specialty Molecules Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Board of Directors of Anshul Specialty Molecules Private Limited
Anshul Specialty Molecules Private Limited is currently managed by 5 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Ashwin Champraj Shroff
Also directs:
Transpek Industry Limited, Excel Industries Limited, Excel Bio Resources Limited and 5 more
|
Director | 14 Nov 2014 | 11 Years 7 Months | Current |
|
Ravi Ashwin Shroff
Also directs:
Transpek Industry Limited, Excel Industries Limited, Excel Bio Resources Limited and 5 more
|
Director | 09 Feb 2010 | 16 Years 5 Months | Current |
|
Shirish Ramchandra Satpute
Also directs:
Anshul Innovative Chemistry Private Limited
|
Whole-Time Director | 01 Apr 2022 | 4 Years 3 Months | Current |
| Ramchandra Neelkanth Bhogale | Director | 27 Nov 2025 | 0 Years 7 Months | Current |
|
Hrishit Ashwin Shroff
Also directs:
Excel Industries Limited, Excel Bio Resources Limited, Mobitrash Recycle Ventures Private Limited and 5 more
|
Director | 27 Nov 2025 | 0 Years 7 Months | Current |
Financials of Anshul Specialty Molecules Private Limited FY 2024 filings available
Anshul Specialty Molecules Private Limited reported revenue of ₹177.17 Cr (up 18% YoY) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Anshul Specialty Molecules Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Nov 2010 | Bank of India | ₹4.95 Cr | Open |
| 08 Sep 2006 | Bank of India | ₹25.88 Cr | Open |
| 19 Nov 2004 | Bank of India | ₹25.88 Cr | Open |
| 23 Feb 1994 | Bank of Baroda | ₹50 Lakh | Open |
| 02 Jul 1985 | Bank of India | ₹4 Lakh | Open |
Total charge records: 8 View all charges
Employees and EPFO Compliance at Anshul Specialty Molecules Private Limited
View historical data on people associated with Anshul Specialty Molecules Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Anshul Specialty Molecules Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Anshul Specialty Molecules Private Limited
GSTIN & GST Filing Data of Anshul Specialty Molecules Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Anshul Specialty Molecules Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Anshul Specialty Molecules Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Anshul Specialty Molecules Private Limited
MSME Payment Delays by Anshul Specialty Molecules Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Anshul Specialty Molecules Private Limited
Subsidiaries & Group Companies of Anshul Specialty Molecules Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Anshul Specialty Molecules Private Limited with ownership details.
MCA Filings & Documents of Anshul Specialty Molecules Private Limited
MCA Filings & Documents of Anshul Specialty Molecules Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Anshul Specialty Molecules Private Limited
Frequently Asked Questions about Anshul Specialty Molecules Private Limited
Anshul Specialty Molecules Private Limited is an active private limited company in the chemicals and materials sector based in Mumbai, Maharashtra, India. It was incorporated on 05 October 1971 (55+ years old) and is registered under CIN U24100MH1971PTC015364. The company has 205 employees.
Anshul Specialty Molecules Private Limited reported revenue of ₹177.17 Cr for FY 2024 (up 18.00% YoY).
The current directors of Anshul Specialty Molecules Private Limited are:
The primary industry of Anshul Specialty Molecules Private Limited is chemicals and materials. The company specifically operates in specialty chemicals. The company is currently active in this sector.
Anshul Specialty Molecules Private Limited can be reached at the registered office: Flexcel Park C Wing 2Nd Floor S.V. Road Near 24 Karat Multiplex Joge, Shwari W, Mumbai, Maharashtra, India – 400102, or through the website anshulchemicals.com.
The authorised capital is ₹3 Cr, and the paid-up capital is ₹29.42 Lakh.